Genomic Valley Biotech Ltd Quarterly Result

Genomic Valley Biotech Ltd Quarterly Result

Image

Genomic Valley Biotech Ltd

NSE: GENOMICVALLEY

Net Profit - Last Quarter

₹ -0.01 Cr.

Last updated on: Jul 29, 2026

Genomic Valley Biotech Ltd Quarterly Results Key Highlights

  • The revenue of Genomic Valley Biotech Ltd for the Mar '26 is ₹ 0.04 crore as compare to the Dec '25 revenue of ₹ 0.05 crore.
  • This represent the decline of -20% The ebitda of Genomic Valley Biotech Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0.01 crore.
  • This represent the decline of -100% The net profit of Genomic Valley Biotech Ltd for the Mar '26 is ₹ -0.01 crore as compare to the Dec '25 net profit of ₹ 0.01 crore.
  • This represent the decline of -200%.

Genomic Valley Biotech Ltd Quarterly Results Analysis

Market Price of Genomic Valley Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Genomic Valley Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
28 Jul 202628.5
27 Jul 202629.5
24 Jul 202628.25
23 Jul 202628.25
22 Jul 202628
21 Jul 202628.55
20 Jul 202630
17 Jul 202630.85
16 Jul 202629.9
15 Jul 202628.56

Historical Revenue of Genomic Valley Biotech Ltd

No data available

* All values are in crore

Historical EBITDA of Genomic Valley Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Genomic Valley Biotech Ltd

No data available

* All values are in crore

Genomic Valley Biotech Ltd News Hub

Genomic Valley Biotech standalone net profit rises 650.00% in the September 2024 quarter

Net profit of Genomic Valley Biotech rose 650.00% to Rs 0.15 crore in the quarter ended September 20

Read more

08 Oct 24

Genomic Valley Biotech to discuss results

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 7 October 202

Read more

03 Oct 24

Genomic Valley Biotech to convene board meeting

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 14 February 2

Read more

11 Feb 25

Genomic Valley Biotech schedules AGM

Genomic Valley Biotech announced that the Annual General Meeting(AGM) of the company will be held on

Read more

07 Dec 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

About Genomic Valley Biotech Ltd

  • Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
  • The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
  • Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses, NFT & DFT etc, manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
  • Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

FAQs for Quarterly Results of Genomic Valley Biotech Ltd

What key financial metrics are included in Genomic Valley Biotech Ltd's quarterly results?

Key financial metrics in Genomic Valley Biotech Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Genomic Valley Biotech Ltd announce its quarterly results?

Genomic Valley Biotech Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Genomic Valley Biotech Ltd's quarterly performance impact its stock price?

Genomic Valley Biotech Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Genomic Valley Biotech Ltd's quarterly results on dividends?

The impact of Genomic Valley Biotech Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Genomic Valley Biotech Ltd's quarterly results?

Yes, Genomic Valley Biotech Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions